A modern multidisciplinary approach to the treatment of enterocutaneous fistulas in Crohn’s disease patients

References

• Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009 Nov 19;361(21):2066–2078.
   PubMed Web of Science ®Google Scholar
• Schwartz DA, Loftus EV Jr., Tremaine WJ, et al. The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology. 2002 Apr;122(4):875–880.
   PubMed Web of Science ®Google Scholar
• Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis. 2002 Jul;8(4):244–250.
   PubMed Web of Science ®Google Scholar
• Gecse K, Khanna R, Stoker J, et al. Fistulizing Crohn’s disease: diagnosis and management. United European Gastroenterol J. 2013 Jun;1(3):206–213.
   PubMed Web of Science ®Google Scholar
• Gribovskaja-Rupp I, Melton GB. Enterocutaneous Fistula: proven Strategies and Updates. Clin Colon Rectal Surg. 2016 Jun;29(2):130–137.
   PubMed Web of Science ®Google Scholar
• Orangio GR. Enterocutaneous fistula: medical and surgical management including patients with Crohn’s disease. Clin Colon Rectal Surg. 2010 Sep;23(3):169–175.
   PubMedGoogle Scholar
• Visschers RG, van Gemert WG, Winkens B, et al. Guided treatment improves outcome of patients with enterocutaneous fistulas. World J Surg. 2012 Oct;36(10):2341–2348.
   PubMed Web of Science ®Google Scholar
• Klek S, Forbes A, Gabe S, et al. Management of acute intestinal failure: A position paper from the European Society for Clinical Nutrition and Metabolism (ESPEN) Special Interest Group. Clin Nutr. 2016 Dec;35(6):1209–1218.
   PubMed Web of Science ®Google Scholar
• Ashkenazi I, Turegano-Fuentes F, Olsha O, et al. Treatment Options in Gastrointestinal Cutaneous Fistulas. Surg J (N Y). 2017 Jan;3(1):e25–e31.
   PubMed Web of Science ®Google Scholar
• Tonolini M, Magistrelli P. Enterocutaneous fistulas: a primer for radiologists with emphasis on CT and MRI. Insights Imaging. 2017 Dec;8(6):537–548.
   PubMed Web of Science ®Google Scholar
• Amiot A, Setakhr V, Seksik P, et al. Long-term outcome of enterocutaneous fistula in patients with Crohn’s disease treated with anti-TNF therapy: a cohort study from the GETAID. Am J Gastroenterol. 2014 Sep;109(9):1443–1449.
   PubMed Web of Science ®Google Scholar
• Parsi MA, Lashner BA, Achkar JP, et al. Type of fistula determines response to infliximab in patients with fistulous Crohn’s disease. Am J Gastroenterol. 2004 Mar;99(3):445–449.
   PubMed Web of Science ®Google Scholar
• Fujiwara K, Inoue T, Yorifuji N, et al. Effect of adalimumab on an enterocutaneous fistula in patients with Crohn’s disease: a case series. Int Med. 2015;54(20):2603–2607.
   PubMed Web of Science ®Google Scholar
• Gomez-Senent S, Barreiro-de-Acosta M, Garcia-Sanchez V. Enterocutaneous fistulas and Crohn s disease: clinical characteristics and response to treatment. Revista espanola de enfermedades digestivas: organo oficial de la Sociedad Espanola de Patologia Digestiva. 2013 Jan;105(1):3–6.
   PubMed Web of Science ®Google Scholar
• Cougard PA, Desjeux A, Berdah S, et al. Healing of anastomotic enterocutaneous fistulae due to Crohn’s disease by anti-tNF-alpha antibodies. Inflamm Bowel Dis. 2010 Oct;16(10):1632–1633.
   PubMed Web of Science ®Google Scholar
• Visschers RG, Olde Damink SW, Winkens B, et al. Treatment strategies in 135 consecutive patients with enterocutaneous fistulas. World J Surg. 2008 Mar;32(3):445–453.
   PubMed Web of Science ®Google Scholar
• Yang SK, Xiao L, Zhang H, et al. Significance of serum procalcitonin as biomarker for detection of bacterial peritonitis: a systematic review and meta-analysis. BMC Infect Dis. 2014 Aug;22(14):452.
   Google Scholar
• Sridharan P, Chamberlain RS. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills? Surg Infect (Larchmt). 2013 Dec;14(6):489–511.
   PubMed Web of Science ®Google Scholar
• Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017 Mar;43(3):304–377.
   PubMed Web of Science ®Google Scholar
• Feagins LA, Holubar SD, Kane SV, et al. Current strategies in the management of intra-abdominal abscesses in Crohn’s disease. Clin Gastroenterol Hepatol. 2011 Oct;9(10):842–850.
   PubMed Web of Science ®Google Scholar
• Sartelli M, Catena F, Abu-Zidan FM, et al. Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference. World J Emerg Surg. 2017;12:22.
   Google Scholar
• Akpan MR, Ahmad R, Shebl NA, et al. A Review of Quality Measures for Assessing the Impact of Antimicrobial Stewardship Programs in Hospitals. Antibiotics (Basel). 2016 Jan 13;5(1):5.
   PubMed Web of Science ®Google Scholar
• Bassetti M, De Waele JJ, Eggimann P, et al. Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med. 2015 May;41(5):776–795.
   PubMed Web of Science ®Google Scholar
• Long B, Koyfman A. Red Blood Cell Transfusion in the Emergency Department. J Emerg Med. 2016 Aug;51(2):120–130.
   PubMed Web of Science ®Google Scholar
• Greinacher A, Selleng S. How I evaluate and treat thrombocytopenia in the intensive care unit patient. Blood. 2016 Dec 29;128(26):3032–3042.
   PubMed Web of Science ®Google Scholar
• Papa A, Papa V, Marzo M, et al. Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. Inflamm Bowel Dis. 2015 May;21(5):1204–1213.
   PubMed Web of Science ®Google Scholar
• Barletta JF, Bruno JJ, Buckley MS, et al. Stress Ulcer Prophylaxis. Crit Care Med. 2016 Jul;44(7):1395–1405.
   PubMed Web of Science ®Google Scholar
• de Vries FEE, Atema JJ, van Ruler O, et al. A Systematic Review and Meta-analysis of Timing and Outcome of Intestinal Failure Surgery in Patients with Enteric Fistula. World J Surg. 2018 Mar;42(3):695–706.
   PubMed Web of Science ®Google Scholar
• Li G, Ren J, Wang G, et al. Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistulizing Crohn’s disease. Eur J Clin Nutr. 2014 Apr;68(4):441–446.
   PubMed Web of Science ®Google Scholar
• Ravindran P, Ansari N, Young CJ, et al. Definitive surgical closure of enterocutaneous fistula: outcome and factors predictive of increased postoperative morbidity. Colorectal Dis. 2014 Mar;16(3):209–218.
   PubMed Web of Science ®Google Scholar
• Cederholm T, Bosaeus I, Barazzoni R, et al. Diagnostic criteria for malnutrition - An ESPEN Consensus Statement. Clin Nutr. 2015 Jun;34(3):335–340.
   PubMed Web of Science ®Google Scholar
• Wall CL, Day AS, Gearry RB. Use of exclusive enteral nutrition in adults with Crohn’s disease: a review. World J Gastroenterol. 2013 Nov 21;19(43):7652–7660.
   PubMed Web of Science ®Google Scholar
• Parli SE, Pfeifer C, Oyler DR, et al. Redefining “bowel regimen”: pharmacologic strategies and nutritional considerations in the management of small bowel fistulas. Am J Surg. 2018 Aug;216(2):351–358.
   PubMed Web of Science ®Google Scholar
• Yan D, Ren J, Wang G, et al. Predictors of response to enteral nutrition in abdominal enterocutaneous fistula patients with Crohn’s disease. Eur J Clin Nutr. 2014 Aug;68(8):959–963.
   PubMed Web of Science ®Google Scholar
• Forbes A, Escher J, Hebuterne X, et al. ESPEN guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017 Apr;36(2):321–347.
   PubMed Web of Science ®Google Scholar
• Kucharski MA, Wierzbicka A, Tsibulski A, et al. Parenteral and Enteral Nutrition A Bridge to Healing and Biological Therapy In A Patient With Enterocutaneous Fistula and Sepsis Complicated Crohn’s Disease. JPEN Journal of parenteral and enteral nutrition. 2020 May 9.
   PubMed Web of Science ®Google Scholar
• Teubner A, Morrison K, Ravishankar HR, et al. Fistuloclysis can successfully replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula. Br J Surg. 2004 May;91(5):625–631.
   PubMed Web of Science ®Google Scholar
• Wright SJ, Daniells S, Keogh GW. Fistuloclysis: a high-calorie, polymeric formula can be successful. JPEN Journal of parenteral and enteral nutrition. 2013 Jul;37(4):550–553.
   PubMed Web of Science ®Google Scholar
• Gabe SM, Culkin A. Abnormal liver function tests in the parenteral nutrition fed patient. Frontline Gastroenterol. 2010 Jul;1(2):98–104.
   PubMedGoogle Scholar
• Pironi L, Corcos O, Forbes A, et al. Intestinal failure in adults: recommendations from the ESPEN expert groups. Clin Nutr. 2018 Dec;37(6 Pt A):1798–1809.
   PubMed Web of Science ®Google Scholar
• Rahbour G, Siddiqui MR, Ullah MR, et al. A meta-analysis of outcomes following use of somatostatin and its analogues for the management of enterocutaneous fistulas. Ann Surg. 2012 Dec;256(6):946–954.
   PubMed Web of Science ®Google Scholar
• Billiauws L, Bataille J, Boehm V, et al. Teduglutide for treatment of adult patients with short bowel syndrome. Expert Opin Biol Ther. 2017 May;17(5):623–632.
   PubMed Web of Science ®Google Scholar
• Silva JC, Rodrigues A, Carvalho J. Spontaneous Resolution of Enterocutaneous Fistula After Disseminated Tuberculosis Treatment in a Patient With Crohn’s Disease: challenges in Biologic Therapy. Inflamm Bowel Dis. 2020 Jan 1;26(1):e1–e2.
   PubMed Web of Science ®Google Scholar
• Fries W, La Malfa G, Costantino G, et al. Combined approach with biologics and surgery for enterocutaneous fistulas in Crohn’s disease. Inflamm Bowel Dis. 2011 Feb;17(2):671–673.
   PubMed Web of Science ®Google Scholar
• Madarame A, Kimura H, Kunisaki R. Successful Treatment With Ustekinumab for Enterocutaneous Fistulas in Crohn’s Disease. J Crohn’s Colitis. 2020 May 21;14(4):569-570.
   Google Scholar
• Wilhelm P, Kirschniak A, Johannink J, et al. Enterocutaneous fistula in severely active Crohn’s disease: preoperative anti-TNF alpha treatment to limit bowel resection-report of a case. Int J Colorectal Dis. 2019 Feb;34(2):369–373.
   PubMed Web of Science ®Google Scholar
• Garcia-Olmo D, Herreros D, Pascual M, et al. Treatment of enterocutaneous fistula in Crohn’s Disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion. Int J Colorectal Dis. 2009 Jan;24(1):27–30.
   PubMed Web of Science ®Google Scholar
• Panara AJ, Yarur AJ, Rieders B, et al. The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: a cohort study. Aliment Pharmacol Ther. 2014 Apr;39(8):802–810.
   PubMed Web of Science ®Google Scholar
• Barreiro-de Acosta M, Marin-Jimenez I, Panadero A, et al. Recommendations of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn’s Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients. Gastroenterol Hepatol. 2018 Feb;41(2):118–127.
   PubMed Web of Science ®Google Scholar
• Ross H. Operative surgery for enterocutaneous fistula. Clin Colon Rectal Surg. 2010 Sep;23(3):190–194.
   PubMedGoogle Scholar
• Lynch AC, Delaney CP, Senagore AJ, et al. Clinical outcome and factors predictive of recurrence after enterocutaneous fistula surgery. Ann Surg. 2004 Nov;240(5):825–831.
   PubMed Web of Science ®Google Scholar
• Hollington P, Mawdsley J, Lim W, et al. An 11-year experience of enterocutaneous fistula. Br J Surg. 2004 Dec;91(12):1646–1651.
   PubMed Web of Science ®Google Scholar
• Yzet C, Brazier F, Fumery M. Post-operative Entero-cutaneous Fistula Closure by Over-the-Scope Clip in Crohn’s Disease. J Crohn’s Colitis. 2019 Jul 25;13(7):954–955.
   Google Scholar